*Campylobacter hyointestinalis* was first identified from a pig with proliferative enteritis \[[@r6], [@r8]\] and has recently been isolated from both diseased and healthy animals and raw milk \[[@r4], [@r7], [@r9], [@r15]\]. Furthermore, this species was isolated from human diarrheal stool samples \[[@r5], [@r14], [@r16]\]. At present, *C. hyointestinalis* is considered to be an emerging zoonotic pathogen, and its clinical importance and pathogenic mechanism are under evaluation.

Cytolethal distending toxin (CDT), which is a genotoxin capable of directly damaging DNA in target cells, is considered to be a possible virulence factor of various Gram-negative bacteria including *C*. *hyointestinalis*. CDT consists of three subunits, CdtA, CdtB and CdtC, which are encoded by the genes *cdtA*, *cdtB* and *cdtC*, respectively \[[@r3]\]. The CDT holotoxin causes G~2~/M cell cycle arrest, cytoplasmic distension and eventually cell death via apoptosis \[[@r3]\]. Although the pathogenic mechanism of CDT *in vivo* is not well understood, CDT produced by *Campylobacter jejuni* has been reported to cause panmural inflammation with mucosal denudation and necrosis affecting the jejunum, ileum and colon in mice \[[@r10]\].

Recently, we have identified two types of *cdt* gene clusters in *C. hyointestinalis*, namely, the *cdt-I* (Ch*cdt-I*) and *cdt-II* (Ch*cdt-II*) genes from *C. hyointestinalis* strains 022 \[[@r17]\] and ATCC35217^T^ \[[@r12]\], respectively. The toxins encoded by these genes (ChCDT-I and ChCDT-II, respectively) both induced cell distention and death in HeLa cells. However, the homologies between these two ChCDTs were only 25.0, 56.0 and 24.8% in their CdtA, CdtB and CdtC subunits, respectively. Since there was a low homology between ChCDT-I and ChCDT-II, particularly regarding their CdtA and CdtC subunits, which are responsible for binding to receptor molecules, it is possible that their target cells might differ. Thus, ChCDT-I and ChCDT-II may have different pathogenic mechanisms *in vivo*. Therefore, it is important to analyze the distribution of these two *cdt* gene-variants in *C. hyointestinalis* to understand the difference in pathogenesis between ChCDT-I and ChCDT-II. In this study, we have developed a PCR-restriction fragment length polymorphism (PCR-RFLP) assay for the detection and differentiation of Ch*cdt-I* and Ch*cdt-II* in *C. hyointestinalis.* The specificity and sensitivity of the PCR-RFLP assay were evaluated, and the presence and types of *cdt* genes in 35 *C. hyointestinalis* strains, including 12 strains newly isolated from pigs and bovines, were successfully determined by the PCR-RFLP assay.

MATERIALS AND METHODS {#s1}
=====================

Bacterial strains and growth media
----------------------------------

Thirty-five strains of *C. hyointestinalis*, which are described in [Table 1](#tbl_001){ref-type="table"}Table 1.Bacterial strains used in this study and the distribution of Ch*cdt-I* and Ch*cdt-II* genesBacterial speciesStrainOriginChcdt*-I*Chcdt*-II*ReferenceBacterial speciesStrainOrigin*cdtC. hyointestinalis*022Clinical++\[[@r12]\]*C. coli*^a)^ATCC33559PigCc*cdt*ATCC 35217^T^Pig-+\[[@r12]\]*C. coli*^a)^ATCC43478MarmosetCc*cdt*1-1Pig++\[[@r12]\]*C. coli*^a)^CO1-017ClinicalCc*cdt*10-1Gorilla++\[[@r12]\]*C. consisus*ATCC33237Human-2003Bovine++\[[@r12]\]*C. consisus*ATCC51562Human-2030Bovine++\[[@r12]\]*C. curvus*ATCC35224Human-2032Bovine++\[[@r12]\]*C. fetus*^a)^ATCC27374SheepCf*cdt*2033Bovine++\[[@r12]\]*C. helveticus*ATCC51209CatChel*cdt*2034Bovine++\[[@r12]\]*C. hominis*ATCCBAA-381Human-2035Bovine++\[[@r12]\]*C. jejuni*^a)^ATCC33560BovineCj*cdt*2037Bovine++\[[@r12]\]*C. jejuni*^a)^ATCC43432HumanCj*cdt*2038Bovine++\[[@r12]\]*C. jejuni*^a)^B86BovineCj*cdt*2039Bovine++\[[@r12]\]*C. jejuni*^a)^CO2-037ClinicalCj*cdt*3014Bovine++\[[@r12]\]*C. lari*^a)^JCM2530Larus argintatusCl*cdt*3158Bovine++\[[@r12]\]*C. mucosalis*ATCC49352Pig-3197^b)^Bovine++\[[@r12]\]*C. upsaliensis*^a)^ATCC43954DogCu*cdt*3477Bovine++\[[@r12]\]*C. ureolyticus*ATCC33387Human-3535^b)^Bovine++\[[@r12]\]*Arcobacter butzuleri*ATCC49616Clinical-3839^b)^Bovine++\[[@r12]\]*A. cryaerophilus*ATCC43157Pig-3857^b)^Bovine++\[[@r12]\]*A. skirrowii*ATCC51132Unknown-87-4^b)^Monkey++\[[@r12]\]*Citrobacter freundii*ATCC43864Unknown-94-6Elephant++\[[@r12]\]*Enterobacter cloacae*NBPC 12935Unknown-SSPork-+\[[@r12]\]*Escherichia coli*^a)^ATCC11775Human-130206DCC11^b)^Bovine++This study*Escherichia coli*^a)^ATCC25922Clinical-130206DCC12Bovine++This study*Escherichia coli*^a)^GB1371ClinicalEc*cdt-I*130325D2aC1Bovine++This study*E. albertii^a)^*19982ClinicalEa*cdt*141007D1C1Bovine++This study*Haemophilus ducreyi*^a)^ATCC700724HumanHd*cdt*141007D2C1^b)^Bovine++This study*Helicobacter fennelliae*^a)^ATCC35684HumanHf*cdt*S1C-1Pig-+This study*H. hepaticus*^a)^ATCC51448MouseHh*cdt*S2 TDNEFB-1Pig++This study*H. pylori*ATCC43504Human-S2CB-1Pig-+This study*H. pylori*ATCC43629Human-S3C-1Pig++This study*Klebsiera oxytoca*ATCC8724Unknown-S4TVB-1Pig-+This study*K. pneumoniae*ATCC13883Unknown-S5C-1Pig++This study*Providencia alcalifaciens*^a)^GTC02020UnknownPa*cdt*S5TDNPFB-1Pig-+This study*P. heimbachae*ATCC35613Penguin-*P. rettgeri*ATCC29944Human-*P. rustigianii*ATCC33673Human-*P. stuartii*ATCC29914Human-*Salmonella enterica*ATCCBAA-664Unknown-*Vibrio cholerae*VcN16961Unknown-*Vibrio cholerae*VcBT-AP32541Unknown-*Vibrio cholerae*Vc129Unknown-a) Bacterial species known to possess *cdt* genes, b) Undigested PCR product was observed from these strains, +: Indicates that the gene was identified by Ch*cdt-B* gene-based PCR-RFLP assay, -: Indicates that the gene was not identified by Ch*cdt*-B gene-based PCR-RFLP assay., were examined in this study. Among them, 23 strains were known to possess Ch*cdt-I* and/or Ch*cdt-II* \[[@r12]\], and the other 12 strains were newly isolated from pigs and bovines. A total of 42 bacterial strains other than *C. hyointestinalis* including 17 strains of 11 other *Campylobacter* species and 25 strains of 20 non-*Campylobacter* species were also included in this study ([Table 1](#tbl_001){ref-type="table"}).

*Campylobacter*, *Helicobacter* and *Arcobacter* spp. were grown on blood agar \[blood agar base No. 2 (Oxoid Ltd., Basingstoke, U.K.) supplemented with 5% (v/v) defibrinated horse blood (Nippon Bio Supp. Center, Tokyo, Japan)\] under anaerobic conditions (10% CO~2~, 10% H~2~ and 80% N~2~) at 37°C for 2 days or more. *Vibrio* spp. were cultured using TCBS agar (NISSUI Pharmaceutical Co., Ltd., Tokyo, Japan), and other bacteria were grown in Luria--Bertani broth (Becton, Dickinson and Co., Franklin Lakes, NJ, U.S.A.) at 37°C overnight.

DNA preparation
---------------

Template DNAs for PCR were prepared by the boiling method as previously reported \[[@r1], [@r11]\]. Briefly, bacterial colonies grown on appropriate agar plates were suspended in 500 *µl* of TE buffer (10 mM Tris-HCl \[pH 8.0\] and 1 mM ethylenediaminetetraacetic acid). Bacterial suspensions were boiled for 10 min, kept on ice for 10 min and centrifuged at 20,000 ×*g* for 10 min. Then, the supernatants were collected and used as DNA templates for PCR. As positive controls for the PCR and RFLP assays, pET28a Ch*cdt-IB* and pET28a Ch*cdt-IIB,* which carry the Ch*cdt-IB* and Ch*cdt-IIB* genes of *C. hyointestinalis* strains 022 and ATCC35217^T^, respectively, were used \[[@r12], [@r17]\].

PCR amplification assay
-----------------------

PCR was performed with ChCdt-BF (5′-GCTACTTGGAATATGCAAGG-3′) and ChCdt-BR (5′-TGGTTCTCTATTRAAATCWCC-3′) primer set using an Applied Biosystems Veriti^®^ Thermal Cycler (Thermo Fisher Scientific, Waltham, MA, U.S.A.). Each PCR mixture contained 0.5 and 0.15 *µ*M of ChCdt-BF and ChCdt-RF primers, respectively, 1 *µl* of DNA template, 0.2 mM of each dNTP, 1 × r*Taq* DNA polymerase buffer and 0.5 U of r*Taq* DNA polymerase (Takara Bio Inc., Otsu, Japan) in a total volume of 20 *µl*. The samples were subjected to an initial denaturation step at 94°C for 3 min followed by 30 cycles of amplification, each cycle consisting of 94°C for 30 sec, 54°C for 30 sec and 72°C for 30 sec. A final extension step at 72°C for 3 min was included. PCR products were analyzed by electrophoresis using a 2% PrimeGel™ Agarose LE gel (Takara Bio Inc.), and bands were visualized with ultraviolet (UV) light after staining with ethidium bromide (1 *µg*/m*l*). Images were captured on a ChemiDoc system (Bio-Rad Laboratories, Inc., Hercules, CA, U.S.A.).

RFLP assay
----------

PCR products (2 to 5 *µl*; 100 to 200 *ng*) were digested with either 4 U of EcoT14-I or 2 U of EcoT14-I and 2 U of DdeI (New England Biolabs Inc., Ipswich, MA, U.S.A.) under 1 ×H buffer or 1 ×K buffer (Takara Bio Inc.) in a final volume of 10 *µl* at 37°C overnight. Then, the digested PCR products were analyzed by 3% PrimeGel™ Agarose LE gel electrophoresis as described above.

Detection limit of the PCR-RFLP assay
-------------------------------------

The *C. hyointestinalis* strains, ATCC35217^T^, 022 and 3197, were cultured on blood agar under anaerobic conditions at 37°C for 2 days, and the colonies that grew were suspended in sterile phosphate-buffered saline. The density of each bacterial culture was adjusted to OD~600~=1.0 and then 10-fold serially diluted in phosphate-buffered saline, and DNA templates were prepared from 100 *µl* of each dilution by the boiling method as described above. Then, PCR assays were carried out with these DNA templates. Furthermore, to determine the viable bacterial count, 100 *µl* of each dilution was spread on blood agar plates in triplicate and cultured at 37°C for 2 days under anaerobic conditions, and then, the number of colonies on each plate was counted.

Colony hybridization assay
--------------------------

The distribution of Ch*cdt-IB* and Ch*cdt-IIB* in 12 newly isolated strains of *C. hyointestinalis* was examined by colony hybridization assay as described previously \[[@r11]\], with minor modiﬁcations. In brief, Ch*cdt-IB* and Ch*cdt-IIB* gene-probes were prepared by PCR with each primer set ([Table S1](#pdf_001){ref-type="supplementary-material"}) using *C. hyointestinalis* strains 022 (Ch*cdt-IB*) and ATCC35217^T^(Ch*cdt-IIB*) as DNA templates, and the obtained PCR products were purified from agarose gel using the Wizard SV^®^ Gel and PCR clean-up system (Promega Corporation, Madison, WI, U.S.A.). Strains were grown on a nitrocellulose membrane (GE Healthcare U.K. Ltd., Buckinghamshire, U.K.) overlaid on blood agar plates under anaerobic conditions at 37°C overnight. Colonies were lysed, and DNA was denatured *in situ* by the alkaline lysis method followed by UV cross-linking with a UV crosslinker (CX-2000; UVP LLC, Upland, CA, U.S.A.). The processed nitrocellulose membranes were hybridized with each gene probe, and radioactivity was visualized using an FLA-7000 biomolecular imager (GE Healthcare U.K. Ltd.).

Sequencing of cdt genes and PCR products
----------------------------------------

To determine the entire nucleotide sequence of the *cdt* gene cluster in 12 newly obtained *C. hyointestinalis* strains ([Table 1](#tbl_001){ref-type="table"}), PCR was performed with a combination of forward primers targeting upstream of *cdtA* or *cdtB* and reverse primers targeting downstream of *cdtC* ([Table S2](#pdf_001){ref-type="supplementary-material"}). Each PCR mixture contained 0.5 *µ*M of each primer, 1 *µl* of DNA template, 0.2 mM of each dNTP, 1 ×Ex *Taq^®^* DNA polymerase buffer and 1.0 U of Ex *Taq^®^* DNA polymerase in a total volume of 20 *µl*. The samples were subjected to an initial denaturation step of 3 min at 94°C followed by 30 cycles of 94°C for 30 sec, 50°C for 30 sec and 72°C for 90 sec to 2 min, and then a final extension step at 72°C for 3 to 5 min. If a PCR product of the expected size was obtained, the PCR product was purified using a PCR clean-up system (QIAGEN GmbH, Hilden, Germany) for sequencing. The sequencing reactions were performed by the chain termination method with the BigDye^®^ Terminator v1.1 cycle sequencing kit (Thermo Fisher Scientific). Nucleotide sequences were determined using an ABI PRISM*^®^* 3130-Avant Genetic analyzer (Thermo Fisher Scientific). The sequence upstream of Ch*cdt-IB* in *C. hyointestinalis* strains 130206DCC11, 130206DCC12, 130325D2aC1, 141007D1C1, S2TDNEFB-1, S3C-1 and S5C-1, and that of Ch*cdt-IIB* in *C. hyointestinalis* strain 141007D2C1, were determined with the primers listed in [Table S2](#pdf_001){ref-type="supplementary-material"} by genome walking as described previously \[[@r12]\].

Undigested PCR products (approximately 500 bp in length) were purified from agarose gel by using the Wizard^®^ SV Gel and PCR clean-up system (Promega Corporation). The nucleotide sequences of undigested PCR products were determined as described above, analyzed using MEGA6, and compared with the sequences of Ch*cdt-IB* and Ch*cdt-IIB*.

Nucleotide sequence accession numbers
-------------------------------------

The *cdt* gene-sequences determined in this study were deposited to the DNA Data Bank of Japan (DDBJ) with the accession numbers LC175774 to LC175800.

RESULTS {#s2}
=======

Evaluation of ChcdtB amplification by PCR
-----------------------------------------

By comparing published *cdtB* sequences of *C. hyointestinalis* (GenBank accession nos. AB218983 and AB373951) and those of other *Campylobacter* spp. (AB274783, AB274793, AB274802, AB872889 and AB872911), forward and reverse primers (ChCdt-BF and ChCdt-BR) were designed from the conserved regions of Ch*cdt-IB* and Ch*cdt-IIB*. To evaluate whether these primers can amplify Ch*cdt-IB* and Ch*cdt-IIB*, PCR was carried out using recombinant plasmids, pET28a carrying Ch*cdt-IB* and pET28a carrying Ch*cdt-IIB*, as positive controls. PCR of the positive controls, pET28a carrying Ch*cdt-IB* and pET28a carrying Ch*cdt-IIB*, gave the expected size of the PCR product (507 or 516 bp) in each case ([Fig. S1](#pdf_001){ref-type="supplementary-material"}). Sequence analysis further confirmed that these PCR products were amplified from Ch*cdt-IB* and Ch*cdt-IIB* gene-fragments (data not shown).

The sensitivity of the PCR assay was evaluated with the 35 *C*. *hyointestinalis* strains listed in [Table 1](#tbl_001){ref-type="table"}. A PCR product of the expected size was obtained from 23 strains, which were previously reported to possess Ch*cdt-I* and/or Ch*cdt-II* ([Table 1](#tbl_001){ref-type="table"}). Furthermore, a PCR product of the same size was also obtained from 12 newly isolated *C. hyointestinalis* strains in which the presence of Ch*cdt-I* and/or Ch*cdt-II* was confirmed by colony hybridization assay and sequence analysis as described below. Then, the specificity of the PCR assay was evaluated with a total of 42 strains including 17 strains of 11 other *Campylobacter* spp. and 25 strains of 20 non-*Campylobacter* spp. as listed in [Table 1](#tbl_001){ref-type="table"}. Irrespective of their *cdt* gene-possession, no PCR product was obtained from those 42 strains.

Sequence analysis of cdt gene cluster in 12 C. hyointestinalis strains
----------------------------------------------------------------------

To calculate the sensitivity of the PCR-RFLP assay developed in this study, we further evaluated the distribution of *cdt* genes in 12 *C. hyointestinalis* strains, which were newly isolated from pigs and bovines, by colony hybridization assay. The Ch*cdt-IB* gene-probe was reacted with 8 strains (130206DCC11, 130206DCC12, 130325D2aC1, 141007D1C1, 141007D2C1, S2TDNEFB-1, S3C-1 and S5C-1), while the Ch*cdt-IIB* gene-probe was reacted with all the strains (data not shown). Furthermore, the entire nucleotide sequences of these *cdt* gene clusters were determined as described in the Materials and Methods section. The sizes of individual *cdt* genes and the homology of each *cdt* gene are summarized in [Table S3](#pdf_001){ref-type="supplementary-material"}. These data indicated that the 12 *C. hyointestinalis* strains possessed Ch*cdt-I* and/or Ch*cdt-II*, except for 1 strain, 141007D2C1, in which *cdtA* was missing.

Detection limit of the PCR-RFLP assay
-------------------------------------

The detection limit of this assay was evaluated using *C. hyointestinalis* ATCC35217^T^(Ch*cdt-II*), 022 (Ch*cdt-I* and Ch*cdt-II*) and 3197 (Ch*cdt-I*, Ch*cdt-II* and Ch*cdt* homologue gene) strains. The detection limits of this PCR assay were determined to be 4.9 ± 1.8 × 10^2^, 4.4 ± 0.47 × 10^2^ and 4.9 ± 3.2 × 10^2^ colony-forming units (CFU)/20 *µl* of reaction mixture for strains ATCC35217^T^, 022 and 3197, respectively.

A ChcdtB-based PCR-RFLP assay
-----------------------------

EcoT14-I restriction enzyme was selected for the PCR-RFLP assay by comparing the sequences of Ch*cdt-IB* and Ch*cdt-IIB*. When the PCR products obtained from the positive controls were digested with EcoT14-I, the Ch*cdt-IB* DNA fragment yielded two bands of 363 and 144 bp ([Fig. 1A](#fig_001){ref-type="fig"}Fig. 1.(A) PCR-RFLP with EcoT14-I to evaluate the presence of the Ch*cdtB* gene in *C. hyointestinalis*. PCR products digested with EcoT14-I were analyzed by electrophoresis on a 3% agarose gel. Undigested PCR product in lane 5 was extracted from the gel, purified, and subjected to a sequencing analysis. Undigested PCR product was identified as a possible Ch*cdtB* variant gene. Lanes: M, 100-bp DNA ladder (Takara Bio Inc.); N, PCR product of *C. hyointestinalis* 3197 strain; 1, pET28a Ch*cdt-IB*; 2, pET28a Ch*cdt-IIB*; 3, *C. hyointestinalis* ATCC35217^T^ strain; 4, *C. hyointestinalis* 022 strain; 5, *C. hyointestinalis* 3197 strain. (B) PCR-RFLP with EcoT14-I and DdeI to evaluate the presence of the Ch*cdtB* gene in *C. hyointestinalis*. Lanes: M, 100-bp DNA ladder (Takara Bio Inc.); N, PCR product of *C. hyointestinalis* 3197 strain; 1, pET28a Ch*cdt-IB*; 2, pET28a Ch*cdt-IIB*; 3, *C. hyointestinalis* ATCC35217^T^ strain; 4, *C. hyointestinalis* 022 strain; 5, *C. hyointestinalis* 3197 strain., lane 1), and in the case of Ch*cdt-IIB*, the fragment sizes were 261 and 255 bp ([Fig. 1A](#fig_001){ref-type="fig"}, lane 2). We then evaluated the utility of the PCR-RFLP assay with the PCR products obtained from 35 *C. hyointestinalis* strains ([Table 1](#tbl_001){ref-type="table"}). Among the 35 strains, the *cdt* gene-possession profile of 23 strains was previously analyzed by colony hybridization assay and the same types of *cdt* were successfully identified by their RFLP patterns, even though both Ch*cdt-I* and Ch*cdt-II* were present ([Fig. 1A](#fig_001){ref-type="fig"}, lane 4). When the PCR products obtained from 12 other strains were analyzed by the RFLP assay, their RFLP patterns indicated that all *C. hyointestinalis* strains contained Ch*cdt-IIB* and 7 strains additionally possessed Ch*cdt-IB* ([Table 1](#tbl_001){ref-type="table"}). These data indicated that the PCR-RFLP assay could identify the *cdt* gene-profile. However, undigested PCR products were obtained from 7 strains (3197, 3535, 3839, 3857, 87--4, 130206DCC11 and 141007D2C1) among 35 strains when digested with EcoT14-I ([Fig. 1A](#fig_001){ref-type="fig"}, lane 5).

The undigested PCR products obtained from 7 strains were purified and sequenced. This analysis revealed that the undigested PCR products carried sequences of *cdt* genes with only 45--46% and 64--66% homologies to the corresponding regions of Ch*cdt-IB* and Ch*cdt-IIB*, respectively. These data indicated that the *C. hyointestinalis* strains might possess new variants of *cdt* genes.

To avoid the possibility of obtaining ambiguous results from the PCR-RFLP assay, we further digested the PCR products with DdeI in addition to EcoT14-I. When the PCR products obtained from positive controls were digested with these enzymes, the Ch*cdt-IB* gene-fragment and Ch*cdt-IIB* gene-fragment were theoretically digested to yield fragments of 363, 101 and 43 bp, and 261, 113, 70, 41 and 31 bp, respectively. The agarose gel separation result is shown in [Fig. 1B.](#fig_001){ref-type="fig"} Furthermore, the PCR products of the *cdtB* gene-homologue were theoretically digested to yield fragments of 302, 72, 51, 27 and 24 bp ([Fig. 1B](#fig_001){ref-type="fig"}). Then, when we evaluated the utility of this modified PCR-RFLP assay with the PCR products obtained from 35 *C. hyointestinalis* strains, Ch*cdt-IB,* Ch*cdt-IIB* and *cdtB* gene-homologue could be clearly distinguished from one another.

DISCUSSION {#s3}
==========

Although the clinical significance of *C. hyointestinalis* infection has not yet been clearly established, *C. hyointestinalis* is implicated as a pathogen of both humans and animals. We have previously reported that two types of the *cdt* genes, namely Ch*cdt-I* and Ch*cdt-II*, are present in *C. hyointestinalis* and encode biologically active CDTs \[[@r12], [@r17]\]. Therefore, CDT is a candidate virulence factor in *C. hyointestinalis.* To understand the importance of CDT in the pathogenesis of *C. hyointestinalis*, we attempted to establish a PCR-RFLP assay for the detection and differentiation of Ch*cdt-I* and Ch*cdt-II* in *C. hyointestinalis*. Since *cdtB* was previously demonstrated to be more conserved than *cdtA* and *cdtC* in *C. jejuni*, *C. coli* and *C. fetus* \[[@r2]\], various *cdtB* gene-based multiplex PCR and PCR-RFLP assays have been developed to detect and differentiate *Campylobacter* species \[[@r1], [@r11], [@r13]\]. In this study, we have developed a Ch*cdtB*-based PCR-RFLP assay that can detect and differentiate between Ch*cdt-I* and Ch*cdt-II*.

The sensitivity and specificity of the PCR-RFLP assay were shown to be 100%. Furthermore, the PCR-RFLP assay could clearly identify the *cdt* gene-profile, even though *C. hyointestinalis* contained both Ch*cdt-I* and Ch*cdt-II* ([Fig. 1A](#fig_001){ref-type="fig"}, lane 4). Kamei *et al*. have reported that Ch*cdt-II* may be ubiquitously conserved in *C. hyointestinalis* \[[@r12]\]. In this study, we evaluated the presence of *cdt* genes using 12 *C. hyointestinalis* strains that were newly isolated from pigs and bovines. As expected, Ch*cdt-IIB* was detected in all the *C. hyointestinalis* strains, while Ch*cdt-IB* was also detected in 7 strains ([Table 1](#tbl_001){ref-type="table"}). Furthermore, the presence of Ch*cdt-IIA* and Ch*cdt-IIC* in these 12 strains was analyzed by colony hybridization assay, and their nucleotide sequences were determined by sequence analysis ([Table S3](#pdf_001){ref-type="supplementary-material"}). Although Ch*cdt-IIA* was not detected in *C. hyointestinalis* strain 141007D2C1, 11 other strains were demonstrated to possess Ch*cdt-IIA*, Ch*cdt-IIB* and Ch*cdt-IIC*. It appears that Ch*cdt-IIB* and Ch*cdt-IIC* are ubiquitously present in *C. hyointestinalis* and may be suitable target genes for the detection and identification of this species.

The isolation of *C. hyointestinalis* is difficult if *C. jejuni* and *C. coli* are targeted for isolation because of its susceptibility to cephem antibiotics, which are included in the modified charcoal-cefoperazone-deoxycholate agar and Bolton broth that are normally used for the isolation of *C. jejuni* and *C. coli*. Therefore, a PCR-based method is required to detect this bacterium before initiating cultivation. The *cdtB* gene-based PCR assay developed in this study could detect *C. hyointestinalis* with 100% sensitivity and specificity ([Table 1](#tbl_001){ref-type="table"}). The detection limit of the assay was determined to be approximately 10^2^ CFU/20 *µl* of reaction mixture. These data indicate that the PCR assay developed in this study is useful for the detection of *C. hyointestinalis.*

However, PCR products obtained from some template DNAs of *C. hyointestinalis* strains remained undigested by EcoT14-I ([Fig. 1A](#fig_001){ref-type="fig"}, lane 5). A sequence analysis of these PCR fragments showed that these strains carry the homologous *cdtB* gene sequence, indicating the detection of a new *cdt* gene-variant of *C. hyointestinalis*. Therefore, we further included DdeI digestion in the *cdtB* gene-based PCR-RFLP assay to distinguish not only Ch*cdt-IB* and Ch*cdt-IIB* but also a possible new *cdtB* gene-variant. The *cdtB* gene-based PCR-RFLP assay with EcoT14-I and DdeI could clearly distinguish three different *cdtB* genes as PCR products including Ch*cdt-IB* and Ch*cdt-IIB* and a possible new *cdtB* gene-variant in the 35 *C. hyointestinalis* strains listed in [Table 1](#tbl_001){ref-type="table"}. Further analysis to characterize the *cdt* gene-variant is currently ongoing in our laboratory.

In conclusion, the Ch*cdtB* gene-based PCR-RFLP assay developed in this study is useful to detect and differentiate not only Ch*cdt-I* and Ch*cdt-II* but also a possible new *cdt* gene-variant in *C. hyointestinalis.* The ubiquitous presence of Ch*cdt-IIB* among the tested *C. hyointestinalis* strains also confirmed it to be an appropriate target gene for the identification of *C. hyointestinalis*. Further studies are required for the evaluation of the *cdtB* gene-based PCR-RFLP assay for the detection and differentiation of *cdt* genes present in *C. hyointestinalis*.

Supplementary Material
======================

###### Supplement figure and table

We thank Dr. Rupak K. Bhadra (CSIR-Indian Institute of Chemical Biology, Kolkata, India) for the critical reading of the manuscript. This study was performed in partial fulfillment of the requirements of a Ph.D. thesis for N. Hatanaka from the Graduate School of Life and Environmental Sciences, Osaka Prefecture University, Osaka, Japan.
